Infectious Disease and HIV-specialist Physicians
HIV, Sexual Health, MSM, Recreational Drug Use, Rapid ART
HIV Waiting Room: Test Your Skills in Managing These Patients – Newly diagnosed young male who has sex with men (MSM) with a history of recreational drug use
Launch Date: November 15, 2019
Expiration Date: November 15, 2020
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an educational grant from Gilead Sciences, Inc.
This activity is intended for infectious disease and HIV specialist physicians and other clinicians involved in the care of patients with HIV infection
Statement of Need/Program Overview
MSM, particularly those of color, have a higher risk of contracting HIV. Substance use is both common in the MSM population and an additional risk factor for HIV; clinicians should be aware of risk factors both for contracting HIV and for decreased adherence to antiretroviral therapy (ART) in this population. This case-based, interactive activity focuses on a young, African American MSM who uses drugs recreationally, creating a clinical scenario addressing rapid ART, importance of adherence to an ART regimen, substance use, and mental health issues that a patient in this population may experience.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 80% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 80%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Christian B. Ramers, MD, MPH
Consultant/Independent Contractor: AbbVie Inc., Gilead Sciences, Inc., ViiV Healthcare Limited; Grant/Research Support: AbbVie Inc., Gilead Sciences, Inc.; Speaker’s Bureau: AbbVie Inc., Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare Limited
Richard A. Elion, MD, MA
Consultant/Independent Contractor: Gilead Sciences, Inc.; Grant/Research Support: Gilead Sciences, Inc., ViiV Healthcare Limited; Honoraria: Gilead Sciences, Inc., ViiV Healthcare Limited; Speaker’s Bureau: Gilead Sciences, Inc., ViiV Healthcare Limited; Other/Royalty (Describe): Works with Trio Health, Inc., who receives grants from Gilead Sciences, Inc., ViiV Healthcare Limited
The following planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann, Gena Dolson, MS, Stacey JP Ullman, MHS, Jim Kappler, PhD
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Course Viewing Requirements
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above